Rh(D) 同种免疫的预防：成本效益分析。
Prevention of Rh(D) alloimmunization: a cost-benefit analysis.
作者信息
Baskett T F, Parsons M L
机构信息
Department of Obstetrics and Gynaecology, Dalhousie University, Halifax, NS.
出版信息
CMAJ. 1990 Feb 15;142(4):337-9.
The Rh Programme of Nova Scotia was established in 1964 for the prevention and treatment of Rh(D) alloimmunization. The program's effectiveness in preventing the condition has been established previously. Because of increasing budget restraint in health care we decided to examine the cost-effectiveness of the program by comparing the cost of prevention (office administration fees, program staff salaries and the price of Rh immune globulin) with the cost of health care services required in addition to standard obstetric procedures and neonatal care in 80 cases of Rh(D) alloimmunization treated from 1982 to 1986. Neonatal intensive care accounted for 80.1% of the additional health care expenses; an extra 512 hospital days for such care constituted 65.7% of the total treatment expense. The cost per case prevented ($1495) was 2.7 times less than the cost per case treated ($3986).
新斯科舍省的Rh项目于1964年设立，旨在预防和治疗Rh(D)同种免疫。该项目在预防该病方面的有效性此前已得到证实。由于医疗保健预算限制日益增加，我们决定通过比较预防成本（办公室管理费、项目工作人员薪水以及Rh免疫球蛋白价格）与1982年至1986年期间治疗的80例Rh(D)同种免疫病例在标准产科程序和新生儿护理之外所需的医疗保健服务成本，来研究该项目的成本效益。新生儿重症监护占额外医疗保健费用的80.1%；为此护理额外增加的512个住院日占总治疗费用的65.7%。每预防一例的成本（1495美元）比每治疗一例的成本（3986美元）少2.7倍。
Zotero 插件